Results 121 to 130 of about 817,904 (149)

An integrated system for identifying the hidden assassins in traditional medicines containing aristolochic acids. [PDF]

Sci Rep, 2015
Wu L, Sun W, Wang B, Zhao H, Li Y, Cai S, Xiang L, Zhu Y, Yao H, Song J, Cheng YC, Chen S.   +11 more
europepmc   +1 more source

A dual role of AcSDKP in chronic kidney disease: Targeting pericyte-driven fibrosis and vascular repair via VEGF/FGFR1 while eliciting a compensatory FGFR1 upregulation in apoptotic tubular cells. [PDF]

PLoS One
Zhu S, Shi L, Huang L, Cui N, Chen R, Jiang L, Zhang A, Xu Y, Li X.   +8 more
europepmc   +1 more source

Structural Basis for the Inhibition of a Phospholipase A2-Like Toxin by Caffeic and Aristolochic Acids. [PDF]

PLoS One, 2015
Fernandes CA, Cardoso FF, Cavalcante WG, Soares AM, Dal-Pai M, Gallacci M, Fontes MR.   +6 more
europepmc   +1 more source

Integrating machine learning, deep learning, and docking to predict aristolochic acid A carcinogenesis. [PDF]

Front Pharmacol
Li L, Liao J, Chen X, Lin Z, Gong S, Huang J, Bi Z, Wang T, Chia X, Chen L, Xu Y, Liu H, Hao J, Qi J.   +13 more
europepmc   +1 more source

Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone. [PDF]

Arch Toxicol, 2017
Arlt VM, Meinl W, Florian S, Nagy E, Barta F, Thomann M, Mrizova I, Krais AM, Liu M, Richards M, Mirza A, Kopka K, Phillips DH, Glatt H, Stiborova M, Schmeiser HH.   +15 more
europepmc   +1 more source

Aristolochic acid I accelerates lung adenocarcinoma progression coupled with the upregulation of core oncogenic networks: an integrated network toxicology and experimental study. [PDF]

Front Pharmacol
Mo L, Yu F, Peng M, He Y, Xie S, Wu S, Zhang Z, Wang C, Zhao W, Ouyang Y, Yi X, Wang L, Peng X, Huang X, Hu Q, Luo J, Chen X, Yang Z.   +17 more
europepmc   +1 more source

Deletion of decay-accelerating factor in kidney tubular cells mitigates kidney fibrosis in aristolochic acid nephropathy. [PDF]

Am J Physiol Renal Physiol
Yu SM, King E, Khleif S, Cravedi P.
europepmc   +1 more source

Mitochondrial DNA Damage Induced by Aristolochic Acid I: Recognizing the Heart as a Target Organ. [PDF]

Chem Res Toxicol
Kwok HC, Cheng KH, Chan W.
europepmc   +1 more source

Pharmacologic disruption of HuR-RNA interactions prevents maladaptive tubular repair and AKI-to-CKD progression. [PDF]

Am J Physiol Renal Physiol
Wang Z, Liu S, Zhuang L, Qiu Y, Aube J, Wu X, Xu L, Huang Y.   +7 more
europepmc   +1 more source

ZBP1 promotes RIPK1-dependent apoptosis in aristolochic acid nephropathy. [PDF]

Zool Res
Zou Z, Ye K, Chen F, Lin K, Song Y, Li G, Chen C, Wang Y, Ma H, Xu Y.   +9 more
europepmc   +1 more source